Did a Cocaine-Binding Antibody Protect Rat Hearts for a Month?
A rat experiment tested whether a humanized cocaine-binding monoclonal antibody, h2E2, could prevent a measured cardiac response to intravenous cocaine. The investigators used echocardiography, ECG and blood-pressure monitoring after dosing.
The short-term finding
Cocaine increased ejection fraction in the comparison condition. Antibody given one hour beforehand prevented that response in the tested rats. The researchers also observed that the protective effect was much smaller after a week and absent after a month.
Limits of the result
Ejection fraction is one cardiac measure; an unchanged response does not prove elimination of every toxic effect. The intervention was tested in rats, not as an established human treatment. Duration, safety, dose and effects on other cardiovascular outcomes remain separate questions.
The narrow conclusion is time-limited antagonism of a specified cocaine-related cardiac response under the experimental conditions.
Source: Koch SE et al. Pharmacology Research & Perspectives (2023), 11:e01045. doi:10.1002/prp2.1045.



